Cargando…

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2

The sudden emergence of a highly transmissible and pathogenic coronavirus SARS-CoV-2 in December 2019 from China and its rapid global spread has posed an international health emergency. The rapid development of an effective vaccine is imperative to control the spread of SARS-CoV-2. A number of concu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mudgal, Rajat, Nehul, Sanketkumar, Tomar, Shailly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544966/ https://www.ncbi.nlm.nih.gov/pubmed/32931361 http://dx.doi.org/10.1080/21645515.2020.1805992

Ejemplares similares

Shut the Door
Publicado: (1874)

Oestrogen shuts the door on SOX9
por: Mork, Lindsey, et al.
Publicado: (2010)

Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
por: Dubey, Aakriti, et al.
Publicado: (2021)

Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2
por: Bilal, Muhammad, et al.
Publicado: (2020)

Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2
por: Haskologlu, Ismail Celil, et al.
Publicado: (2022)

SARS-CoV-2 Mutations and their Viral Variants
por: Cosar, Begum, et al.
Publicado: (2022)

Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
por: Choudhary, Shweta, et al.
Publicado: (2020)

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Zhang, Chao, et al.
Publicado: (2020)

SARS-CoV-2 (COVID-19) and the Endocrine System
por: Lundholm, Michelle D, et al.
Publicado: (2020)

Thyroiditis and SARS-CoV-2 pandemic: a review
por: Caron, Philippe
Publicado: (2021)

Therapeutic antibodies under development for SARS‐CoV‐2
por: Ma, Zetong, et al.
Publicado: (2021)

Impact of SARS-CoV-2 infection on liver disease
por: Salgüero Fernández, Sergio, et al.
Publicado: (2022)

COVID-19 Shuts Doors to Flu but Keeps Them Open to Rhinoviruses
por: Kiseleva, Irina, et al.
Publicado: (2021)

Attacking the Intruder at the Gate: Prospects of Mucosal Anti SARS-CoV-2 Vaccines
por: Karczmarzyk, Kacper, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections after vaccination: a critical review
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2022)

Laboratory diagnosis of SARS-CoV-2: available approaches and limitations
por: Abduljalil, J.M.
Publicado: (2020)

The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection
por: Huizinga, Gabrielle P, et al.
Publicado: (2020)

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

Natural Immunomodulators Treat the Cytokine Storm in SARS-CoV-2
por: Abbas, Heba Salah, et al.
Publicado: (2023)

The role of environmental factors to transmission of SARS-CoV-2 (COVID-19)
por: Eslami, Hadi, et al.
Publicado: (2020)

Photonics enabled intelligence system to identify SARS-CoV 2 mutations
por: Taha, Bakr Ahmed, et al.
Publicado: (2022)

Could SARS‐CoV‐2 infection affect male fertility and sexuality?
por: delli Muti, Nicola, et al.
Publicado: (2022)

Electrochemical biosensors for the detection of SARS-CoV-2 pathogen and protein biomarkers
por: Zhang, Yintang, et al.
Publicado: (2022)

Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
por: Focosi, Daniele, et al.
Publicado: (2023)

SARS-CoV-2 Burden in Wastewater and its Elimination Using Disinfection
por: Koirala, Prashanna, et al.
Publicado: (2023)

Histologic transformation in lung cancer: when one door shuts, another opens
por: Sato, Yuki, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines: The Mucosal Immunity Imperative
por: Adashi, Eli Y., et al.
Publicado: (2022)

The role of schools in driving SARS-CoV-2 transmission: Not just an open-and-shut case
por: White, Laura F., et al.
Publicado: (2022)

Multifunctional inhibitors of SARS-CoV-2 by MM/PBSA, essential dynamics, and molecular dynamic investigations
por: Kumar, K. Amith, et al.
Publicado: (2021)

Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2
por: Yang, Shujuan, et al.
Publicado: (2021)

Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
por: Ahmad, Firdos, et al.
Publicado: (2022)

An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
por: Spicuzza, Lucia, et al.
Publicado: (2023)

A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
por: Noor, Rashed
Publicado: (2021)

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
por: Karthik, Kumaragurubaran, et al.
Publicado: (2020)

Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view
por: Abduljalil, J.M., et al.
Publicado: (2020)

Application of Nanobiotechnology for Early Diagnosis of SARS-CoV-2 Infection in the COVID-19 Pandemic
por: Sheervalilou, Roghayeh, et al.
Publicado: (2021)

Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review
por: Nanishi, Etsuro, et al.
Publicado: (2022)

SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
por: Trbojević-Akmačić, Irena, et al.
Publicado: (2021)

Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection
por: Chen, Catherine, et al.
Publicado: (2021)

Infección por SARS-CoV-2 y su impacto en la enfermedad hepática
por: Salgüero Fernández, Sergio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ls97pfi7v2aev0jotatd7a1sb6